科学家开发新的白血病治疗方法,利用抗体来瞄准癌症细胞和增强免疫反应。 Scientists develop new leukemia treatment using antibody to target cancer cells and boost immune response.

南卡罗来纳医科大学的研究人员为急性流质白血病建立了一种新的免疫疗法,针对关键的蛋白质途径。 Researchers at the Medical University of South Carolina have created a new immunotherapy for acute myeloid leukemia (AML) that targets a key protein pathway. 该疗法使用双性抗体来杀死白血病细胞并激活免疫系统,在实验室和动物试验中显示出有希望的结果。 The therapy uses a bispecific antibody to both kill leukemia cells and activate the immune system, showing promising results in lab and animal tests. 它可能会为 AML 和其他癌症带来更有效、毒性更小、成本更低的治疗方法。 It could lead to more effective, less toxic, and less expensive treatments for AML and other cancers.